Delivery Order SPE2DB22D3004-SPE2DB25FNN20

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $57K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $10,012.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $27,796.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, and has a firm fixed-price pricing type with an ultimate completion date of November 25, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,954.52, is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $51,492.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of BIKTARVY 50-200-25 MG TABLET, a specialty medication, to support federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,631.07, is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $17,394.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $4,644.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $16,383.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $55,028.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the procurement of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to support...
This federal contract award, valued at $80,530.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30s. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FNN20
    Delivery Order

This federal contract award, valued at $56,988.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, is for the supply of BIKTARVY 50-200-25 MG TABLET pharmaceutical products.

The contract does not have a set-aside designation, indicating the award was made through open competition. Amerisourcebergen, as the prime contractor, will be responsible for delivering the requested pharmaceutical products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This contract is part of a larger IDC valued at $999,999,999 held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military healthcare system.

Generated 5/20/25, 2:29 PM